{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Aura Biosciences, Inc."},"Symbol":{"label":"Symbol","value":"AURA"},"Address":{"label":"Address","value":"85 BOLTON STREET, CAMBRIDGE, Massachusetts, 02140, United States"},"Phone":{"label":"Phone","value":"+1 617 500-8864"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity."},"CompanyUrl":{"label":"Company Url","value":"https://www.aurabiosciences.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Carrie Murray","title":"Vice President-Global Medical Affairs"},{"name":"Elisabet de los Pinos","title":"President, Chief Executive Officer & Director"},{"name":"Janet Jill Hopkins","title":"Chief Medical Officer"},{"name":"Mark Plavsic","title":"Chief Technology Officer"},{"name":"Patrick Nealon","title":"SVP-Clinical Development Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}